Journal article icon

Journal article

Opinion: Maintenance of clinical remission in ANCA-associated vasculitis

Abstract:

A fundamental change in management of antineutrophil cytoplasmic antibody-associated vasculitis in the past 10 years is the early focussed use of aggressive immunosuppression, using regimens comprised of widely available medications. Using a clinical framework to quantify morbidity, we can induce remission in most patients within 3-6 months using glucocorticoids plus methotrexate, cyclophosphamide or rituximab, with additional plasmapheresis when indicated. Difficulty in maintaining remission...

Expand abstract

Actions


Access Document


Publisher copy:
10.1038/nrrheum.2012.188

Authors


Journal:
Nature Reviews Rheumatology
Volume:
9
Issue:
2
Pages:
127-132
Publication date:
2013-02-05
DOI:
EISSN:
1759-4804
ISSN:
1759-4790
URN:
uuid:997017cb-c625-41cf-b8d5-39282feb4bd6
Source identifiers:
384786
Local pid:
pubs:384786
Language:
English

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP